AP Biosciences Inc
TPEX:6945
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
A
|
AP Biosciences Inc
TPEX:6945
|
TW |
|
FBD Holdings PLC
OTC:FBDHF
|
IE |
|
Barbara Bui SA
PAR:BUI
|
FR |
|
T
|
Thai Plastic Industrial (1994) PCL
SET:TPLAS
|
TH |
|
W
|
Way of Will Inc
CNSX:WAY
|
CA |
|
Nerds On Site Inc
F:3NS
|
CA |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de AP Biosciences Inc.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace AP Biosciences
AP Biosciences, Inc. engages in the research and development of new antibody drug and immunotherapy drugs. The company is headquartered in Taipei City, Taipei. The company went IPO on 2023-07-14. The firm develops early candidate drugs and preclinical trials, and develops different monoclonal or bispecific antibody drugs for potential targets, mechanisms of action, and disease characteristics through drug design and existing technology platforms.
- Sede central
- Taiwán TW
- Empleados
- 37
- Fecha de salida a bolsa
- 14 jul., 2023